| Melanie Gartside, DC | |
|
1720 S Walton Blvd Ste 6, Bentonville, AR 72712-7533 | |
| (618) 210-8571 | |
| Not Available |
| Full Name | Melanie Gartside |
|---|---|
| Gender | Female |
| Speciality | Chiropractic |
| Experience | 11 Years |
| Location | 1720 S Walton Blvd Ste 6, Bentonville, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912324047 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 16040 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Invision Family Chiropractic Llc | 0446475586 | 2 |
News Archive
A large cohort study of women who have had one or more previous cesarean sections suggests that attempting a vaginal birth in a subsequent pregnancy is associated with higher health risks to both the mother and the infant than electing for another cesarean.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
In the event of an infection, the immune system releases messenger substances. These molecules can either activate immune cells to defeat invading pathogens, or inhibit them to prevent an excessive immune reaction. For this, the immune system has to decide very quickly what mixture of activating and inhibiting messenger molecules leads to a successful defence.
The researchers studied the genetic overlap between the risk of having these psychiatric disorders and measures of social communicative competence - the ability to socially engage with other people successfully - during middle childhood to adolescence.
RegeneRx Biopharmaceuticals, Inc. announced that its strategic partner, G-treeBNT Co. Ltd., has filed an IND with the Korean Ministry of Food and Drug Safety for a Phase IIB/III clinical trial with RGN-259 (designated GBT-201 in Korea and the licensed Pan Asia territory) for the treatment of patients with dry eye syndrome.
› Verified 6 days ago
| Provider Name | Invision Family Chiropractic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1255758397 PECOS PAC ID: 0446475586 Enrollment ID: O20140707000532 |
News Archive
A large cohort study of women who have had one or more previous cesarean sections suggests that attempting a vaginal birth in a subsequent pregnancy is associated with higher health risks to both the mother and the infant than electing for another cesarean.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
In the event of an infection, the immune system releases messenger substances. These molecules can either activate immune cells to defeat invading pathogens, or inhibit them to prevent an excessive immune reaction. For this, the immune system has to decide very quickly what mixture of activating and inhibiting messenger molecules leads to a successful defence.
The researchers studied the genetic overlap between the risk of having these psychiatric disorders and measures of social communicative competence - the ability to socially engage with other people successfully - during middle childhood to adolescence.
RegeneRx Biopharmaceuticals, Inc. announced that its strategic partner, G-treeBNT Co. Ltd., has filed an IND with the Korean Ministry of Food and Drug Safety for a Phase IIB/III clinical trial with RGN-259 (designated GBT-201 in Korea and the licensed Pan Asia territory) for the treatment of patients with dry eye syndrome.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melanie Gartside, DC 1720 S Walton Blvd Ste 6, Bentonville, AR 72712-7533 Ph: (618) 210-8571 | Melanie Gartside, DC 1720 S Walton Blvd Ste 6, Bentonville, AR 72712-7533 Ph: (618) 210-8571 |
News Archive
A large cohort study of women who have had one or more previous cesarean sections suggests that attempting a vaginal birth in a subsequent pregnancy is associated with higher health risks to both the mother and the infant than electing for another cesarean.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
In the event of an infection, the immune system releases messenger substances. These molecules can either activate immune cells to defeat invading pathogens, or inhibit them to prevent an excessive immune reaction. For this, the immune system has to decide very quickly what mixture of activating and inhibiting messenger molecules leads to a successful defence.
The researchers studied the genetic overlap between the risk of having these psychiatric disorders and measures of social communicative competence - the ability to socially engage with other people successfully - during middle childhood to adolescence.
RegeneRx Biopharmaceuticals, Inc. announced that its strategic partner, G-treeBNT Co. Ltd., has filed an IND with the Korean Ministry of Food and Drug Safety for a Phase IIB/III clinical trial with RGN-259 (designated GBT-201 in Korea and the licensed Pan Asia territory) for the treatment of patients with dry eye syndrome.
› Verified 6 days ago
Dr. Brandon Matthew Fitch, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 211 Ne A St, Bentonville, AR 72712 Phone: 479-273-9715 | |
Ozark Valley Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1401 Sw 14th St Ste 9, Bentonville, AR 72712 Phone: 479-595-8726 Fax: 479-282-0444 | |
Dr. Parker Alan Swiggart, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2308 Se 28th St Ste 8, Bentonville, AR 72712 Phone: 479-250-9834 Fax: 479-250-9834 | |
Dr. Bethany Anne Winther Galimore, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1720 S Walton Blvd Ste 6, Bentonville, AR 72712 Phone: 479-464-0834 Fax: 479-464-0836 | |
Morter Wellness, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3201 Ne 11th St Ste 13, Bentonville, AR 72712 Phone: 479-268-4477 Fax: 479-268-4477 | |
Dr. Joseph Michael Dik, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3400 Macy Rd, Ste 30, Bentonville, AR 72712 Phone: 479-273-5855 Fax: 479-273-5010 | |
Dr. John Thomas Sullivan, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 303 Southwest 16th Street, Suite #7, Bentonville, AR 72712 Phone: 479-271-8100 Fax: 479-271-8548 |